Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title:Editorial (Thematic Issue: Vitamin D in Health and Disease)
Volume: 14 Issue: 3
Author(s): Ilka Nemere
Affiliation:
Export Options
About this article
Cite this article as:
Nemere Ilka, Editorial (Thematic Issue: Vitamin D in Health and Disease), Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2014; 14 (3) . https://dx.doi.org/10.2174/187152221403150521104553
DOI https://dx.doi.org/10.2174/187152221403150521104553 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
20
Related Articles
-
Chemotherapy and Cardiotoxicity in Hematologic Malignancies
Current Cancer Drug Targets Indole-3-Carbinol (I3C) and its Major Derivatives: Their Pharmacokinetics and Important Roles in Hepatic Protection
Current Drug Metabolism Small Molecular Inhibitors of p-STAT3: Novel Agents for Treatment of Primary and Metastatic CNS Cancers
Recent Patents on CNS Drug Discovery (Discontinued) CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges
Recent Patents on Anti-Cancer Drug Discovery Radiopharmaceuticals to In Vivo Characterize Adrenal Incidentalomas:The Integrated Role of Radionuclide and Radiological Techniques
Current Radiopharmaceuticals Pharmacological Interventions to Attenuate Alzheimer’s Disease Progression: The Story So Far
Current Alzheimer Research Inhibitors for Metastasis Development
Recent Patents on Anti-Cancer Drug Discovery ETS Proteins and MMPs: Partners in Invasion and Metastasis
Current Drug Targets The Cross-talk between Tristetraprolin and Cytokines in Cancer
Anti-Cancer Agents in Medicinal Chemistry Imiquimod
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Bugs and Drugs: Oncolytic Virotherapy in Combination with Chemotherapy
Current Pharmaceutical Biotechnology Telomere Maintenance as Therapeutic Target in Embryonal Tumours
Anti-Cancer Agents in Medicinal Chemistry Patent Selections:
Recent Patents on Biotechnology Pharmacogenomics of Breast Cancer Targeted Therapy: Focus on Recent Patents
Recent Patents on DNA & Gene Sequences Nanomaterials in the Pharmaceuticals: Occurrence, Behaviour and Applications
Current Pharmaceutical Design Apoptosis Induction by Erucylphosphohomocholine via the 18 kDa Mitochondrial Translocator Protein: Implications for Cancer Treatment
Anti-Cancer Agents in Medicinal Chemistry The Potency of Refined Mouse Models: Implications for Clinical Trials
Current Cancer Therapy Reviews An Update on the Recent Advances in Cubosome: A Novel Drug Delivery System
Current Drug Metabolism Anticancer Antifolates: Current Status and Future Directions
Current Pharmaceutical Design Ultraviolet B Regulation of Transcription Factor Families: Roles of Nuclear Factor-kappa B (NF-κB) and Activator Protein-1 (AP-1) in UVB-Induced Skin Carcinogenesis
Current Cancer Drug Targets